Peter P. Liu

Active 1992–2025

Also published as
PETER P. LIU
119
Papers
27,204
Citations
87
h-index
116
i10-index

Citations

Citations per year for Peter P. Liu1986: 1 citations1991: 1 citations1992: 4 citations1993: 3 citations1994: 3 citations1995: 14 citations1996: 9 citations1997: 21 citations1998: 22 citations1999: 24 citations2000: 22 citations2001: 44 citations2002: 57 citations2003: 87 citations2004: 103 citations2005: 147 citations2006: 157 citations2007: 212 citations2008: 228 citations2009: 238 citations2010: 263 citations2011: 238 citations2012: 280 citations2013: 214 citations2014: 226 citations2015: 211 citations2016: 181 citations2017: 188 citations2018: 170 citations2019: 614 citations2020: 1,311 citations2021: 1,089 citations2022: 628 citations2023: 437 citations2024: 673 citations2025: 259 citations2026: 10 citations1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,832 citing papers, 22.3% of this breakdownChina: 1,385 citing papers, 10.9% of this breakdownCanada: 966 citing papers, 7.6% of this breakdownUnited Kingdom: 883 citing papers, 6.9% of this breakdownItaly: 696 citing papers, 5.5% of this breakdownGermany: 632 citing papers, 5% of this breakdownFrance: 415 citing papers, 3.3% of this breakdownNetherlands: 349 citing papers, 2.7% of this breakdownJapan: 328 citing papers, 2.6% of this breakdownAustralia: 316 citing papers, 2.5% of this breakdownSpain: 314 citing papers, 2.5% of this breakdownSwitzerland: 249 citing papers, 1.9% of this breakdown
0%22.3%Other 26.3%

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Immunology and Microbiology2.9%
  • Neuroscience2%
  • Engineering1.6%
  • Health Professions1.2%
  • Other3.5%

Topics

  • Heart Failure Treatment and Management4.7%
  • COVID-19 Clinical Research Studies4.4%
  • Cardiovascular Function and Risk Factors4%
  • Cardiac Fibrosis and Remodeling2.9%
  • Viral Infections and Immunology Research2.5%
  • Long-Term Effects of COVID-192.3%
  • Other79.2%

Coauthors

All papers

Open in search
  1. Targeting metabolic dysregulation for fibrosis therapy

    Authors: , , , , - Nature Reviews Drug Discovery 2019 cited by 528

  2. Dilated cardiomyopathy

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2019 cited by 674

  3. Myocarditis

    Authors: , , - The Lancet 2011 cited by 738

  4. Role of innate and adaptive immune mechanisms in cardiac injury and repair

    Authors: , , - Nature reviews. Immunology 2015 cited by 632

  5. Myocarditis in the Setting of Cancer Therapeutics

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 445

  6. Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study

    Authors: , , , , , , , - New England Journal of Medicine 2006 cited by 1,970

  7. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , , , - Circulation 2017 cited by 585

  8. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Li Liu, Youqin Yan, Mingyu Liu, Manhua Chen, Xiao‐Jing Zhang, Xinghuan Wang, Rhian M. Touyz, Jiahong Xia, Binghong Zhang, Xiaodong Huang, Yufeng Yuan, Rohit Loomba, Peter P. Liu, Hongliang Li - Circulation Research 2020 cited by 1,185

  9. Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure

    Authors: , , , , , , , , , , , , , , , , , , - Nature Cardiovascular Research 2022 cited by 63

  10. A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rhian M. Touyz, Peter P. Liu, Rohit Loomba, Zhi‐Gang She, Hongliang Li - Science Translational Medicine 2021 cited by 60

  11. Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lan Bai, Hailong Yang, Zhibing Lu, Hongliang Li - Cell Metabolism 2021 cited by 100

  12. Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter P. Liu, Rohit Loomba, Yibin Wang, Hongliang Li - Science Translational Medicine 2021 cited by 47

  13. The Science Underlying COVID-19

    Authors: , , , - Circulation 2020 cited by 835

  14. Applications of 3D printing in cardiovascular diseases

    Authors: , , , , , - Nature Reviews Cardiology 2016 cited by 421

  15. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

    Authors: , , , , , , , , , , - Nature Medicine 2003 cited by 482

  16. Advances in the Understanding of Myocarditis

    Authors: , - Circulation 2001 cited by 493

  17. Impaired Heart Contractility in Apelin Gene–Deficient Mice Associated With Aging and Pressure Overload

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Research 2007 cited by 301

  18. Apelin is a positive regulator of ACE2 in failing hearts

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 184

  19. Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Tu, Jacob A. Udell, Sean Virani, Richard Ward, Darren E. R. Warburton, Sean Wharton, Jennifer Zymantas, Diane Hua‐Stewart, Peter P. Liu, Sheldon W. Tobe - Canadian Medical Association Journal 2022 cited by 52

  20. Impact of Oxypurinol in Patients With Symptomatic Heart Failure

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2008 cited by 389

  21. Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases

    Authors: , , - Physiological Reviews 2018 cited by 97

  22. Iron Overload Decreases Ca V 1.3-Dependent L-Type Ca 2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation

    Authors: , , , , , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2011 cited by 87

  23. Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 49

  24. State of the Art: Using Natriuretic Peptide Levels in Clinical Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2008 cited by 837